+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Intra-abdominal Infections Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803327
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc.
  • AtoxBio Inc.
  • Dainippon Sumitomo Pharma
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MORE
The report on the global intra-abdominal infections market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global intra-abdominal infections market to grow with a CAGR of 5.10% over the forecast period from 2019-2025. The study on intra-abdominal infections market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on intra-abdominal infections market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global intra-abdominal infections market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global intra-abdominal infections market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing awareness about the intra-abdominal infections
  • Rising elderly population
2) Restraints
  • The excessive production capacity of antimicrobials
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global intra-abdominal infections market is segmented on the basis of diagnosis, and drugs.

The Global Intra-abdominal Infections Market by Diagnosis
  • Blood Tests
  • Abdominal X-Ray
  • Computed Tomography (CT)
  • Ultrasound
The Global Intra-abdominal Infections Market by Drugs
  • Metronidazole
  • Clindamycin
  • Chloramphenicol
  • Ceftriaxone
  • Other Drugs
Company Profiles
The companies covered in the report include
  • AstraZeneca Plc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • AtoxBio Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Dainippon Sumitomo Pharma
  • Bayer Healthcare Pharmaceutical Inc.
  • Bristol Myers Squibb Company
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the intra-abdominal infections market.
2. Complete coverage of all the segments in the intra-abdominal infections market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global intra-abdominal infections market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc.
  • AtoxBio Inc.
  • Dainippon Sumitomo Pharma
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Intra-abdominal Infections Market Highlights
2.2. Intra-abdominal Infections Market Projection
2.3. Intra-abdominal Infections Market Regional Highlights

3. Global Intra-abdominal Infections Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Diagnosis
3.4.2. Growth Matrix Analysis by Drugs
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Intra-abdominal Infections Market

4. Intra-abdominal Infections Market Macro Indicator Analysis

5. Global Intra-abdominal Infections Market by Diagnosis
5.1. Blood Tests
5.2. Abdominal X-ray
5.3. Computed Tomography (CT)
5.4. Ultrasound

6. Global Intra-abdominal Infections Market by Drugs
6.1. Metronidazole
6.2. Clindamycin
6.3. Chloramphenicol
6.4. Ceftriaxone
6.5. Other Drugs

7. Global Intra-abdominal Infections Market by Region 2019-2025
7.1. North America
7.1.1. North America Intra-abdominal Infections Market by Diagnosis
7.1.2. North America Intra-abdominal Infections Market by Drugs
7.1.3. North America Intra-abdominal Infections Market by Country
7.2. Europe
7.2.1. Europe Intra-abdominal Infections Market by Diagnosis
7.2.2. Europe Intra-abdominal Infections Market by Drugs
7.2.3. Europe Intra-abdominal Infections Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Intra-abdominal Infections Market by Diagnosis
7.3.2. Asia-Pacific Intra-abdominal Infections Market by Drugs
7.3.3. Asia-Pacific Intra-abdominal Infections Market by Country
7.4. RoW
7.4.1. RoW Intra-abdominal Infections Market by Diagnosis
7.4.2. RoW Intra-abdominal Infections Market by Drugs
7.4.3. RoW Intra-abdominal Infections Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Intra-abdominal Infections Market
8.2. Companies Profiles
8.2.1. AstraZeneca Plc.
8.2.2. Merck & Co., Inc.
8.2.3. Pfizer Inc.
8.2.4. AtoxBio Inc.
8.2.5. Teva Pharmaceutical Industries Ltd.
8.2.6. Dainippon Sumitomo Pharma
8.2.7. Bayer Healthcare Pharmaceutical Inc.
8.2.8. Bristol Myers Squibb Company

9. Appendix
9.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AstraZeneca Plc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • AtoxBio Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Dainippon Sumitomo Pharma
  • Bayer Healthcare Pharmaceutical Inc.
  • Bristol Myers Squibb Company
Note: Product cover images may vary from those shown
Adroll
adroll